Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Taro Pharmaceutical Indus Q3 EPS $0.19 May Not Compare To $0.87 Estimate, Sales $139.20M Miss $163.12M Estimate

Author: Michael Horton | January 24, 2023 05:45pm
Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.87 by 78.16 percent. This is a 72.86 percent decrease over earnings of $0.70 per share from the same period last year. The company reported quarterly sales of $139.20 million which missed the analyst consensus estimate of $163.12 million by 14.66 percent. This is a 0.15 percent increase over sales of $139.00 million the same period last year.

Posted In: TARO